Karuna Therapeutics has hired Charmaine Lykins as its chief commercial officer. She arrives at Karuna following a stint as Acadia Pharmaceuticals’ SVP, global product planning and CMO.

“Charmaine is an accomplished leader who has dedicated her career to delivering medicines to people living with psychiatric and neurological conditions in the U.S. and globally,” said Karuna CEO, president and chairman Dr. Steve Paul in a statement. “Her commercialization experience and contributions in launching neuropsychiatric medicines will be invaluable to us in this new role, where she will be responsible for the planning and execution of an integrated commercial strategy as we progress our late-stage clinical pipeline and transition to a commercial-stage company.”